Equities

Immunovia AB (publ)

Immunovia AB (publ)

Actions
Health CarePharmaceuticals & Biotechnology
  • Price (SEK)177.20
  • Today's Change-4.20 / -2.32%
  • Shares traded16.40k
  • 1 Year change-5.34%
  • Beta1.6715
Data delayed at least 15 minutes, as of May 20 2019 15:19 BST.
More ▼

Events & Activity

  • IMMNOV:STO price moved over +1.51% to 161.20
  • IMMNOV:STO price rises above 200-day moving average to 164.40 at 10:00 BST
  • IMMNOV:STO trading volume exceeds daily average by +15.54%
  • IMMNOV:STO price rises above 50-day moving average to 168.60 at 10:09 BST
  • IMMNOV:STO price rises above 15-day moving average to 164.40 at 10:00 BST

Key statistics

As of last trade, Immunovia AB (publ) (IMMNOV:STO) traded at 177.20, 38.44% above the 52 week low of 128.00 set on Oct 26, 2018.
52-week range
Today
128.00Oct 26 2018273.50Aug 14 2018
Markit short selling activity
Low
Med
High
Open181.00
High181.00
Low175.40
Bid176.40
Offer177.20
Previous close181.40
Average volume27.22k
Shares outstanding17.32m
Free float9.40m
P/E (TTM)--
Market cap3.14bn SEK
EPS (TTM)-5.02
SEK
Data delayed at least 15 minutes, as of May 20 2019 15:19 BST.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.